REGULATORY
Deregulation Panel Proposes Giving Private Companies Access to National Health Database to Promote New Drug Development
The Regulatory Reform Promotion Council issued on June 6 its recommendation to Prime Minister Shinzo Abe, calling for the provisioning of data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) to private companies…
To read the full story
Related Article
- Deregulation Panel Pushes PMDA to Digitalize Process
June 6, 2018
REGULATORY
- Japan to Clarify Non-Clinical Data Waivers for Repurposed Drugs, Ease Sakigake Rules
July 24, 2026
- Share of Negative-Margin WPPs Rises to 6.9%, Wholesalers Cite Communication Gap
July 24, 2026
- MHLW Unveils Preventive Healthcare Plan Focused on Dementia, Other Areas
July 24, 2026
- MHLW Eyes Limited Charge Exemptions for OTC-Like Topical Drugs
July 24, 2026
- MHLW Panel Voices Disappointment over Efluelda Launch Delay
July 24, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





